31st week of 2020 patent applcation highlights part 11 |
Patent application number | Title | Published |
20200237837 | LACTIC ACID BACTERIUM, DRUG, FOOD OR DRINK, AND FEED WHICH CONTAIN THE LACTIC ACID BACTERIUM | 2020-07-30 |
20200237838 | RECOMBINANT RHABDOVIRUS ENCODING FOR CCL21 | 2020-07-30 |
20200237839 | REPLICATION COMPETENT ATTENUATED VACCINIA VIRUSES WITH DELETION OF THYMIDINE KINASE WITH AND WITHOUT THE EXPRESSION OF HUMAN FLT3L OR GM-CSF FOR CANCER IMMUNOTHERAPY | 2020-07-30 |
20200237840 | ISOLATION OF PLANT EXTRACTS | 2020-07-30 |
20200237841 | TOPICAL TREATMENTS INCORPORATING CANNABIS SP. DERIVED BOTANICAL DRUG PRODUCT | 2020-07-30 |
20200237842 | SOYBEAN SEED EXTRACT, METHOD FOR PRODUCING THE SAME AND USES THEREOF | 2020-07-30 |
20200237843 | COMPOSITION FOR THE TREATMENT OF CONSTIPATION | 2020-07-30 |
20200237844 | BOYSENBERRY, APPLE, AND BLACKCURRANT COMPOSITIONS AND METHODS OF PREPARATION AND USE THEREFOR | 2020-07-30 |
20200237845 | HOT FLASH AMELIORANT | 2020-07-30 |
20200237846 | Cortex lycii tea formula | 2020-07-30 |
20200237847 | Herbal composition for metabolic syndromes and method of treatment thereof | 2020-07-30 |
20200237848 | Cosmetic and pharmaceutical compositions each containing aloe extract and upland rice extract | 2020-07-30 |
20200237849 | COMPOSITIONS AND METHODS FOR TREATING BETA-AMYLOID RELATED DISEASES | 2020-07-30 |
20200237850 | Medical Preparation and Method for Enhancing Tissue Oxygenation in Case of Diabetic Foot | 2020-07-30 |
20200237851 | LISINOPRIL FORMULATIONS | 2020-07-30 |
20200237852 | Small Molecule Enhancers of Paneth Cell Function and Differentiation | 2020-07-30 |
20200237853 | METHODS FOR TREATING HYPOTENSION | 2020-07-30 |
20200237854 | METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST | 2020-07-30 |
20200237855 | TREATMENT OF PTSD | 2020-07-30 |
20200237856 | METHOD OF TREATING PATIENTS WITH HEPATORENAL SYNDROME TYPE 1 | 2020-07-30 |
20200237857 | AMPHIPHILIC ANTIMICROBIAL HYDROGEL | 2020-07-30 |
20200237858 | DAPTOMYCIN FORMULATIONS AND USES THEREOF | 2020-07-30 |
20200237859 | AQUEOUS SUSPENSIONS OF CYCLOSPORIN | 2020-07-30 |
20200237860 | HSP70 BASED COMBINATION THERAPY | 2020-07-30 |
20200237861 | METHODS OF DIAGNOSING AND TREATING VASCULAR ASSOCIATED MACULOPATHY AND SYMPTOMS THEREOF | 2020-07-30 |
20200237862 | Liquid Formalation of a VEGF Antagonist | 2020-07-30 |
20200237863 | Combination Therapy of Fractionated Radiation and SAPC-DOPS for the Treatment of Tumors | 2020-07-30 |
20200237864 | METHODS AND COMPOSITIONS FOR TREATING FIBROTIC INTERSTITIAL LUNG DISEASE | 2020-07-30 |
20200237865 | Compositions for Treating Pathological Calcification Conditions, and Methods Using Same | 2020-07-30 |
20200237866 | Combination of AS1411 and SAPC-DOPS for the Treatment of Glioblastoma Multiforme | 2020-07-30 |
20200237867 | METHODS AND DEVICES FOR PROMOTING NERVE GROWTH AND REGENERATION | 2020-07-30 |
20200237868 | OSTEOPONTIN AS A TREATMENT FOR NEURONAL LESIONS | 2020-07-30 |
20200237869 | GM-CSF FOR TREATING REFRACTORY NON-TUBERCULOUS MYCOBACTERIA INFECTIONS | 2020-07-30 |
20200237870 | METHODS OF MITIGATING TOXIC EFFECTS OF VESICANTS AND CAUSTIC GAS | 2020-07-30 |
20200237871 | METHODS FOR MITIGATING LIVER INJURY AND PROMOTING LIVER HYPERTROPHY, REGENERATION AND CELL ENGRAFTMENT IN CONJUNCTION WITH RADIATION AND/OR RADIOMIMETIC TREATMENTS | 2020-07-30 |
20200237872 | METHODS OF ENHANCING PROTECTION AGAINST ORGAN AND VASCULAR INJURY, HEMATOPOIETIC RECOVERY AND SURVIVAL IN RESPONSE TO TOTAL BODY RADIATION/CHEMICAL EXPOSURE | 2020-07-30 |
20200237873 | SYSTEMS AND METHODS FOR ANGIOGENIC TREATMENT IN WOUND HEALING | 2020-07-30 |
20200237874 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | 2020-07-30 |
20200237875 | FORMULATIONS AND METHODS FOR TREATMENT OF FIBROMYALGIA AND RELATED MYOFASCIAL PAIN DISORDERS | 2020-07-30 |
20200237876 | SEMAGLUTIDE IN MEDICAL THERAPY | 2020-07-30 |
20200237877 | RAPID-ACTING INSULIN FORMULATION COMPRISING A SUBSTITUTED ANIONIC COMPOUND | 2020-07-30 |
20200237878 | COMPOSITIONS AND METHODS FOR TREATING PSEUDOANEURYSM | 2020-07-30 |
20200237879 | TOLERIZATION REDUCES INTOLERANCE TO PEGLOTICASE AND PROLONGS THE URATE LOWERING EFFECT (TRIPLE) | 2020-07-30 |
20200237880 | REDUCING IMMUNOGENICITY TO PEGLOTICASE | 2020-07-30 |
20200237881 | REDUCING IMMUNOGENICITY TO PEGLOTICASE | 2020-07-30 |
20200237882 | Compositions and Methods for Treating Pathological Calcification and Ossification | 2020-07-30 |
20200237883 | STABLE FORMULATIONS FOR CNS DELIVERY OF ARYLSULFATASE A | 2020-07-30 |
20200237884 | PHARMACEUTICAL COMPOSITIONS | 2020-07-30 |
20200237885 | VACCINES FOR TREATMENT AND PREVENTION OF CANCER | 2020-07-30 |
20200237886 | COSTIMULATION OF CHIMERIC ANTIGEN RECEPTORS BY MYD88 AND CD40 POLYPEPTIDES | 2020-07-30 |
20200237887 | MODIFIED STRAIN OF SALMONELLA ENTERICA TYPHI | 2020-07-30 |
20200237888 | COMPOSITIONS COMPRISING RECOMBINANT PROBIOTIC BACTERIA AND METHODS OF USE THEREOF | 2020-07-30 |
20200237889 | MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION | 2020-07-30 |
20200237890 | Immunogenic Compositions for Use in Pneumococcal Vaccines | 2020-07-30 |
20200237891 | BRUCELLA CANIS VACCINE FOR DOGS | 2020-07-30 |
20200237892 | FLAVIVIRUS PEPTIDE SEQUENCES, EPITOPES, AND METHODS AND USES THEREOF | 2020-07-30 |
20200237893 | RECOMBINANT MEASLES VIRUS EXPRESSING ZIKA VIRUS PROTEINS AND THEIR APPLICATIONS | 2020-07-30 |
20200237894 | PCV2 ORF2 CARRIER PLATFORM | 2020-07-30 |
20200237895 | MAYARO VIRUS CONSENSUS ANTIGENS, DNA ANTIBODY CONSTRUCTS FOR USE AGAINST MAYARO VIRUS, AND COMBINATIONS THEREOF | 2020-07-30 |
20200237896 | Photochemical Preparation Method for Autologous Plasma Inactivated Vaccine for Treating Aids | 2020-07-30 |
20200237897 | Recombinant Bivalent Inactivated Vaccine Against Foot-and-Mouth Disease Virus, Preparation Method and Use Thereof | 2020-07-30 |
20200237898 | VACCINES INTELLIGENTLY PRODUCED BY EPITOPE RECOMBINATION (VIPER) FOR INFLUENZA | 2020-07-30 |
20200237899 | MUTATIONS THAT CONFER GENETIC STABILITY TO ADDITIONAL GENES IN INFLUENZA VIRUSES | 2020-07-30 |
20200237900 | Endothelium-Specific Nucleic Acid Regulatory Elements and Methods and Use Thereof | 2020-07-30 |
20200237901 | BIOACTIVE PREPARATIONS SPECIFIC AGAINST VARIOLA VIRUS INFECTION MODEL STRAINS AND APPLICATIONS THEREOF | 2020-07-30 |
20200237902 | USE OF INACTIVATED NONREPLICATING MODIFIED VACCINIA VIRUS ANKARA (MVA) AS MONOIMMUNOTHERAPY OR IN COMBINATION WITH IMMUME CHECKPOINT BLOCKING AGENTS FOR SOLID TUMORS | 2020-07-30 |
20200237903 | NUCLEIC ACID NANOSTRUCTURE PLATFORM FOR ANTIGEN PRESENTATION AND VACCINE FORMULATIONS FORMED THEREFROM | 2020-07-30 |
20200237904 | Methods and Compositions Useful for Treating Cancer | 2020-07-30 |
20200237905 | COMBINATION THERAPY WITH A BET INHIBITOR, A BCL-2 INHIBITOR AND AN ANTI-CD20 ANTIBODY | 2020-07-30 |
20200237906 | Pharmaceutical Composition of Humanized Monoclonal Anti-PD-L1 Antibody | 2020-07-30 |
20200237907 | Methods of Treating Cancer Using Compositions of Antibodies and Carrier Proteins with Antibody Pretreatment | 2020-07-30 |
20200237908 | haNK CETUXIMAB COMBINATIONS AND METHODS | 2020-07-30 |
20200237909 | METHODS OF TREATING OR PREVENTING BREAST CANCER METASTASES USING ANTIBODIES TO JAGGED1 AND CHEMOTHERAPEUTIC AGENTS | 2020-07-30 |
20200237910 | TREATMENT OF ADVANCED HER2 EXPRESSING CANCER | 2020-07-30 |
20200237911 | Methods for preventing disulfide bond reduction in cell culture harvest | 2020-07-30 |
20200237912 | METHOD FOR THE TREATMENT OR PREVENTION OF INFECTION-RELATED IMMUNE CONDITIONS USING A COMPOSITION COMPRISING IGM | 2020-07-30 |
20200237913 | FORMULATIONS OF ANTIBODY MOLECULES TO DENGUE VIRUS | 2020-07-30 |
20200237914 | Throat Lozenge | 2020-07-30 |
20200237915 | Cytomegalovirus Vectors Eliciting T Cells Restricted By Major Histocompatibility Complex E Molecules | 2020-07-30 |
20200237916 | OPHTHALMIC FORMULATION AND METHOD FOR AMELIORATING PRESBYOPIA | 2020-07-30 |
20200237917 | REOVIRUSES HAVING MODIFIED SEQUENCES | 2020-07-30 |
20200237918 | Linear Polyester and Semi-Linear Glycidol Polymer Systems: Formulation and Synthesis of Novel Monomers and Macromolecular Structures | 2020-07-30 |
20200237919 | DICLOFENAC TOPICAL FORMULATION | 2020-07-30 |
20200237920 | STABLE INJECTABLE PHARMACEUTICAL COMPOSITION OF NEUROKININ 1 RECEPTOR ANTAGONIST AND PROCESS FOR PREPARATION THEREOF | 2020-07-30 |
20200237921 | METHOD FOR REMOVING ACETALDEHYDE | 2020-07-30 |
20200237922 | BICYCLIC PEPTIDE OLIGONUCLEOTIDE CONJUGATES | 2020-07-30 |
20200237923 | PROTEIN BIOCONJUGATION METHOD | 2020-07-30 |
20200237924 | CONOTOXIN PEPTIDE ANALOGS AND USES FOR THE TREATMENT OF PAIN AND INFLAMMATORY CONDITIONS | 2020-07-30 |
20200237925 | POLYPEPTIDE EYE ABSORPTION ENHANCER AND USE THEREOF | 2020-07-30 |
20200237926 | pHLIP.RTM. targeted delivery of potent cytotoxic compounds | 2020-07-30 |
20200237927 | Combination Therapy for Cancer | 2020-07-30 |
20200237928 | NANOPARTICLE CONJUGATES AND USES THEREOF | 2020-07-30 |
20200237929 | GENE THERAPY TREATMENT OF ATRIAL FIBRILLATION | 2020-07-30 |
20200237930 | FACTOR VIII (FVIII) GENE THERAPY METHODS | 2020-07-30 |
20200237931 | MOLECULES TARGETING SURVIVAL MOTOR NEURON 2 | 2020-07-30 |
20200237932 | CHEMILUMINESCENT PROBES FOR DIAGNOSTICS AND IN VIVO IMAGING | 2020-07-30 |
20200237933 | MAGNETIC NANOPARTICLES FOR DESTROYING PATHOLOGICAL CELLS IN AN INDIVIDUAL | 2020-07-30 |
20200237934 | HSP90-TARGETED INFLAMMATION AND INFECTION IMAGING AND THERAPY | 2020-07-30 |
20200237935 | Macrocyclic Agents for Targeted Dual-Modality PET and MRI Imaging of Cancer | 2020-07-30 |
20200237936 | FIBROBLAST ACTIVATION PROTEIN (FAP)-TARGETED IMAGING AND THERAPY | 2020-07-30 |